Nomination Summary for Clorazepate (N86332)
Nominated Substances: Clorazepate
Nomination Date: 03/31/1986
Nominator: NIEHS, FDA
Rationale: Widespread use including use by pregnant women; development of data on structure-activity relationships with regard to carcinogenic potential; and lack of existing studies.